5859-84-7Relevant academic research and scientific papers
FGFR INHIBITOR AND APPLICATION THEREOF
-
Paragraph 0105; 0107, (2020/01/22)
An azatricyclic compound (as represented by formula I) which acts as an inhibitor of fibroblast growth factor receptors (FGFR), as well as a pharmaceutical composition thereof, a preparation method, and a use therefor in the treatment of FGFR-mediated diseases. The azatricyclic compound exerts an effect by means of participating in the regulation of a plurality of processes such as cell proliferation, apoptosis, migration, neovascularization, and the like. AA%%%Formula (I).
Diastereoselective synthesis of complex cis-hexahydroindanes by reductive alkylation
Kaplan, Hilan Z.,Rendina, Victor L.,Kingsbury, Jason S.
, p. 4620 - 4626 (2013/06/27)
An efficient and operationally simple approach to complex cis-hexahydroindanes is reported. Upon Birch reduction of unprotected, C4-alkylated tetrahydroindanols and electrophilic trapping of the tetrasubstituted enolate, cis-fused products are formed with a new stereogenic quaternary carbon. The reaction is convergent, completely diastereoselective, and shows a broad scope with regard to the electrophile.
